Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 30, 2009

View Archived Issues

Novel Rho kinase inhibitors in early development at Abbott

Merck KGaA claims sodium-glucose transporter inhibitors as antidiabetics

Johns Hopkins University describes novel protease inhibitors for treating HCV infection

HDAC1 inhibitors presented by Novartis for the treatment of cancer

Novel Plk-1 inhibitors identified by 4SC for the treatment of cancer

Abbott claims novel GlyT-1 inhibitors as anxiolytics

UAB, Southern Research and Jubilant Organosys enter joint venture

Cytokinetics discloses preclinical data on novel smooth muscle myosin inhibitors

Antimalaria vaccine elicits functional antibodies in phase I trial in malaria-naive subjects

ICOVIR-17 adenovirus displays enhanced intratumoral distribution and activity in vivo

GW-876008 improves stress-induced rectal hypersensitivity in patients with IBS

Preclinical characterization of RP-1040 disclosed at 2009 AACR-NCI-EORTC meeting

Novartis ends asthma and allergy research agreement with Idera Pharmaceuticals

Multaq approved in E.U. for treatment of atrial fibrillation

ATIR enters advanced clinical testing for graft-versus-host disease

Studies clarify genetic predisposition for Chlamydia trachomatis infections / News in Context

Complete response letter issued for extended indication of telavancin in the U.S.

European Commission approves Micardis for cardiovascular protection indication

EMEA validates ChemGenex's MAA for omacetaxine mepesuccinate

SciClone completes patient enrollment for SCV-07 phase II trial in oral mucositis

Roswell Park physician receives grant to investigate HDAC inhibitors in RCC

Photocure's NDA for Hexvix to be reviewed by FDA in December 2009

Approval of Pharmaxis' Aridol recommended by FDA advisory committee

MDRNA and Vancouver Prostate Center to extend collaboration on bladder cancer project

Encouraging phase II data on K-201 in atopic eczema announced by Moberg Derma

GlaxoSmithKline withdraws U.S. supplemental NDA for Avodart

GlaxoSmithKline discloses promising clinical data on H1N1 vaccine Pandemrix

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...